Remyelinating and neuroprotective treatments in multiple sclerosis

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.4, 2004-04, pp. : 331-347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Approaches to neuroprotective strategies in multiple sclerosis

By Tselis Alex Khan Omar A Lisak Robert P

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 17, 2010-12 ,pp. : 2869-2878

Informa Healthcare

Access to resources Recommend Favorite

Preactive Multiple Sclerosis Lesions Offer Novel Clues for Neuroprotective Therapeutic Strategies

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 1, 2011-02 ,pp. : 68-81

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Disease-Modifying Treatments for Multiple Sclerosis: The Story So Far

By Kieseier Bernd C.

CNS Drugs, Vol. 21, Iss. 6, 2007-01 ,pp. : 483-502

Adis International

Access to resources Recommend Favorite

Disease Modifying Treatments for Multiple Sclerosis: What is on the Horizon?

By Weilbach F.X. Gold R.

CNS Drugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 133-157

Adis International

Access to resources Recommend Favorite

Neutralizing Antibodies to Interferon-β and other Immunological Treatments for Multiple Sclerosis: Prevalence and Impact on Outcomes

By Deisenhammer Florian

CNS Drugs, Vol. 23, Iss. 5, 2009-05 ,pp. : 379-396

Adis International

Access to resources Recommend Favorite